Novel Compounds as PKC-Theta Inhibitors for Treating Autoimmune or Inflammatory Diseases

Abstract Provided herein are novel compounds as PKC-theta inhibitors, pharmaceutical compositions, use of such compounds in treating autoimmune or inflammatory diseases, and processes for preparing such compounds.

Authors

Ram W. Sabnis (ORCID: https://orcid.org/0000-0001-7289-0581)

Publication Details

Journal: ACS Medicinal Chemistry Letters
Published: 2026-10-22
DOI: https://doi.org/10.1021/acsmedchemlett.6c00540
Primary Topic: Protein Kinase Regulation and GTPase Signaling
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Novel Compounds as PKC-Theta Inhibitors for Treating Autoimmune or Inflammatory Diseases

Ram W. Sabnis

Oct 22, 2026

ACS Medicinal Chemistry Letters

Protein Kinase Regulation and GTPase Signaling

article

Novel Compounds as PKC-Theta Inhibitors for Treating Autoimmune or Inflammatory Diseases

Ram W. Sabnis

October 22, 2026article en

Abstract

ACS Medicinal Chemistry Letters

Good health and well-being

Openalex Percentile: Top 24%

Protein Kinase Regulation and GTPase Signaling

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon

Novel Compounds as PKC-Theta Inhibitors for Treating Autoimmune or Inflammatory Diseases — Ram W. Sabnis · ACS Medicinal Chemistry Letters (2026) | TGRS Research Map | TGRS